These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial. Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM. Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667 [Abstract] [Full Text] [Related]
3. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group. Circulation; 2005 Nov 29; 112(22):3495-500. PubMed ID: 16301339 [Abstract] [Full Text] [Related]
4. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women]. Caserta L, Caserta R, Torella M, Perricone F, Nesti E, Sessa M, Tagliaferri A, De Francesco F, De Lucia D, Panariello S. Minerva Ginecol; 2004 Apr 29; 56(2):131-6. PubMed ID: 15258541 [Abstract] [Full Text] [Related]
5. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Høibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrøm E, Sandset PM. Thromb Haemost; 2000 Dec 29; 84(6):961-7. PubMed ID: 11154141 [Abstract] [Full Text] [Related]
6. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey. Lowe GD, Upton MN, Rumley A, McConnachie A, O'Reilly DS, Watt GC. Thromb Haemost; 2001 Aug 29; 86(2):550-6. PubMed ID: 11522002 [Abstract] [Full Text] [Related]
7. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Thromb Haemost; 2002 May 29; 87(5):791-5. PubMed ID: 12038778 [Abstract] [Full Text] [Related]
13. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E. Thromb Res; 2008 Jul 29; 121(6):743-50. PubMed ID: 17804043 [Abstract] [Full Text] [Related]
14. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE. Circulation; 2007 Sep 25; 116(13):1497-503. PubMed ID: 17846285 [Abstract] [Full Text] [Related]
18. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S. Circulation; 2003 Jul 22; 108(3):313-8. PubMed ID: 12847064 [Abstract] [Full Text] [Related]